Christopher Graber
@idsensei.bsky.social
ID doc, steward, dad, fellowship program director
Reposted by Christopher Graber
With UW’s Dr Paul Pottinger and others, new discussion re: fostering ID advocacy in ID fellowship.
They note:
Policies with a negative impact on ID clinical care, public health, & research underscore the importance of mobilizing the field of ID to advocacy
academic.oup.com/ofid/advance... #IDSky
They note:
Policies with a negative impact on ID clinical care, public health, & research underscore the importance of mobilizing the field of ID to advocacy
academic.oup.com/ofid/advance... #IDSky
Amplifying Our Voices: Fostering Advocacy in Infectious Diseases Fellowship
This white paper, devised from the Infectious Diseases Society of America's National Training Program Director annual meeting, outlines practical strategie
academic.oup.com
November 7, 2025 at 1:47 PM
With UW’s Dr Paul Pottinger and others, new discussion re: fostering ID advocacy in ID fellowship.
They note:
Policies with a negative impact on ID clinical care, public health, & research underscore the importance of mobilizing the field of ID to advocacy
academic.oup.com/ofid/advance... #IDSky
They note:
Policies with a negative impact on ID clinical care, public health, & research underscore the importance of mobilizing the field of ID to advocacy
academic.oup.com/ofid/advance... #IDSky
beginning to realize the stages of @idweek.bsky.social attendance according to career stage:
1. The Learner: the student/resident/fellow that goes to learn and absorb.
1. The Learner: the student/resident/fellow that goes to learn and absorb.
October 24, 2025 at 7:35 PM
beginning to realize the stages of @idweek.bsky.social attendance according to career stage:
1. The Learner: the student/resident/fellow that goes to learn and absorb.
1. The Learner: the student/resident/fellow that goes to learn and absorb.
Reposted by Christopher Graber
Feeling inspired seeing so many enthusiastic trainees at #IDWeek2025! We have a 2026-27 opening for our 1-year Transplant ID Advanced Training Program at #UCLA, pls reach out with any questions #IDfellow #TxID @idweek.bsky.social #IDSky @ucla-id-fellowship.bsky.social recruit.apo.ucla.edu/JPF10380
Transplant Infectious Diseases Career Development Position 2026-2027
University of California, Los Angeles is hiring. Apply now!
recruit.apo.ucla.edu
October 24, 2025 at 5:52 PM
Feeling inspired seeing so many enthusiastic trainees at #IDWeek2025! We have a 2026-27 opening for our 1-year Transplant ID Advanced Training Program at #UCLA, pls reach out with any questions #IDfellow #TxID @idweek.bsky.social #IDSky @ucla-id-fellowship.bsky.social recruit.apo.ucla.edu/JPF10380
Well done to all the teams! Time for everyone to start making plans for BugBowl 2026 in DC!
This year’s #IDBugBowl was a HIT! 🐛🏆 Congratulations to our winners from the University of Alabama at Birmingham and all of our participants from the Cleveland Clinic Foundation, Thomas Jefferson University Hospital, and the Calcutta School of Tropical Medicine!
October 23, 2025 at 6:26 PM
Well done to all the teams! Time for everyone to start making plans for BugBowl 2026 in DC!
Get psyched! Come for the ATL-themed puns, stay for the knowledge!
Getting ready for #IDBugBowl @idweek.bsky.social Hope to see y’alll this afternoon. Come and cheer ur team UAB CCF ThomasJefferson and our international team Calcutta Troo Med #IDWeek2025 #IDSky
October 22, 2025 at 6:43 PM
Get psyched! Come for the ATL-themed puns, stay for the knowledge!
Reposted by Christopher Graber
On IDSA’s & HIVMA’s Science Speaks blog: Christopher J. Graber, MD, MPH, FIDSA, explores dalbavancin versus standard therapy for completion of treatment of complicated S. aureus bacteremia. https://bit.ly/4ncqnAt
DOT-ting i's and crossing t's: More evidence for using long-acting glycopeptides to finish therapy of complicated S. aureus bacteremia
A JAMA study looked at dalbavancin versus standard therapy for completion of treatment of complicated S. aureus bacteremia. Read IDSA's Journal Club review.
www.idsociety.org
October 17, 2025 at 12:43 AM
On IDSA’s & HIVMA’s Science Speaks blog: Christopher J. Graber, MD, MPH, FIDSA, explores dalbavancin versus standard therapy for completion of treatment of complicated S. aureus bacteremia. https://bit.ly/4ncqnAt
Looking to do some stewardship and/or hospital epi? Join me, @wbranchelliman.bsky.social, and our crew at VA Greater Los Angeles!
September 29, 2025 at 10:30 PM
Looking to do some stewardship and/or hospital epi? Join me, @wbranchelliman.bsky.social, and our crew at VA Greater Los Angeles!
best admin assistant (and pre-interview Zoom DJ) ever!
Meet Claire Echeverri, administrative assistant in the division of infectious diseases. From managing schedules to supporting fellows and faculty, her adaptability and professionalism keep the division running smoothly. Learn more about Claire here: uclahs.fyi/4m9qGLT
September 23, 2025 at 11:44 PM
best admin assistant (and pre-interview Zoom DJ) ever!
Reposted by Christopher Graber
Colleagues- in case this was missed during summer vacation, please share. I just went to the Bowl again last week and saw Yo-Yo Ma and Angelique Kidjo. The Bowl is not the only reason to be in LA....but it is pretty spectacular. Also my ASP team is just the bee's knees.
Please consider joining our incredible faculty and ASP program at UCLA Health. Los Angeles is an incredible city and always will be. recruit.apo.ucla.edu/JPF10331
September 3, 2025 at 11:27 PM
Colleagues- in case this was missed during summer vacation, please share. I just went to the Bowl again last week and saw Yo-Yo Ma and Angelique Kidjo. The Bowl is not the only reason to be in LA....but it is pretty spectacular. Also my ASP team is just the bee's knees.
the marker of a good journal club is that the fellows have already left for clinic and the attendings are still arguing
August 12, 2025 at 8:02 PM
the marker of a good journal club is that the fellows have already left for clinic and the attendings are still arguing
I demand a randomized controlled trial of hiring people who resign back to their prior jobs. The public deserves nothing less.
Big news: Vinay Prasad is returning to #FDA as head of the center for biologics, @lizzylawrence.bsky.social reports. www.statnews.com/2025/08/09/v...
Vinay Prasad returns to the FDA, weeks after his ouster
HFO HFO Vinay Prasad returns to a top FDA role just weeks after his abrupt dismissal.
www.statnews.com
August 9, 2025 at 3:59 PM
I demand a randomized controlled trial of hiring people who resign back to their prior jobs. The public deserves nothing less.
Moderate immunocompromise (even if overly broadly defined) should not buy you vanc + antipseudomonal for CAP: my latest @idsainfo.bsky.social Journal Club review:
www.idsociety.org/science-spea...
www.idsociety.org/science-spea...
Broad-spectrum antibiotics for moderately immunocompromised patients with CAP: An overdone practice
A study in CID examined broad-spectrum antibiotics in moderately immunocompromised patients with community-acquired pneumonia
www.idsociety.org
August 4, 2025 at 4:22 PM
Moderate immunocompromise (even if overly broadly defined) should not buy you vanc + antipseudomonal for CAP: my latest @idsainfo.bsky.social Journal Club review:
www.idsociety.org/science-spea...
www.idsociety.org/science-spea...
my fellow just put up a slide in case conference with the “distracted boyfriend” meme for linezolid overtaking clindamycin as the “toxin” drug of choice and never have I been more proud as a program director
August 1, 2025 at 7:24 PM
my fellow just put up a slide in case conference with the “distracted boyfriend” meme for linezolid overtaking clindamycin as the “toxin” drug of choice and never have I been more proud as a program director
let’s goooooooooooooo
Coming soon to an IDWeek near you... 👀
Register today for #IDWeek2025 before rates increase this Saturday, Aug. 2: idweek.org/registration
Register today for #IDWeek2025 before rates increase this Saturday, Aug. 2: idweek.org/registration
July 31, 2025 at 3:13 AM
let’s goooooooooooooo
we’ve all been there, right?
July 22, 2025 at 2:31 AM
we’ve all been there, right?
most men aren’t complicated, it turns out (at least as it pertains to UTI)
🚨 IDSA has released the first guidelines for the management and treatment of complicated urinary tract infections (cUTIs)!
The new guidelines simplify the prior definitions of uncomplicated UTIs and cUTIs, & address treatment for cUTIs.
View guidelines: bit.ly/4lUjN1a
The new guidelines simplify the prior definitions of uncomplicated UTIs and cUTIs, & address treatment for cUTIs.
View guidelines: bit.ly/4lUjN1a
July 18, 2025 at 4:18 AM
most men aren’t complicated, it turns out (at least as it pertains to UTI)
you’re damn right I’m giving feedback on every internal medicine LKA question I miss as being a bad question
July 10, 2025 at 8:47 PM
you’re damn right I’m giving feedback on every internal medicine LKA question I miss as being a bad question
good reminder for all the new trainees: antibiotics don’t fix structural abnormalities
July 8, 2025 at 11:01 PM
good reminder for all the new trainees: antibiotics don’t fix structural abnormalities
ID is about so much more than picking the correct antibiotics
There are many important perspectives and ideas to share in medicine at this moment that are more important than mine. But this is a reminder of why I keep doing what I do, despite everything. I would be honored if you took the time to read it. www.nejm.org/doi/full/10....
Libraries Burned, a Life Lived | NEJM
As her patients near the end of life, an infectious disease physician who knows their
stories sometimes needs to step out of her proverbial lane to help them assess and
achieve their goals of care.
www.nejm.org
July 6, 2025 at 3:49 AM
ID is about so much more than picking the correct antibiotics
Reposted by Christopher Graber
On IDSA’s & HIVMA’s Science Speaks blog: A study in OFID examined the impact of antibiotic duration on gut microbiome composition and antimicrobial resistance. Read IDSA’s Journal Club review by Christopher J. Graber, MD, MPH, FIDSA. buff.ly/CDwwOlf
Shorter may be better, but how (and how much better)?
A study in OFID examined the impact of antibiotic duration on gut microbiome composition and antimicrobial resistance.
www.idsociety.org
July 2, 2025 at 6:33 PM
On IDSA’s & HIVMA’s Science Speaks blog: A study in OFID examined the impact of antibiotic duration on gut microbiome composition and antimicrobial resistance. Read IDSA’s Journal Club review by Christopher J. Graber, MD, MPH, FIDSA. buff.ly/CDwwOlf
IDSA Journal Club is back, baby! My latest on the perhaps questionable effect of shortening antimicrobial courses of therapy on the gut microbiome:
www.idsociety.org/science-spea...
www.idsociety.org/science-spea...
Shorter may be better, but how (and how much better)?
A study in OFID examined the impact of antibiotic duration on gut microbiome composition and antimicrobial resistance.
www.idsociety.org
June 27, 2025 at 9:43 PM
IDSA Journal Club is back, baby! My latest on the perhaps questionable effect of shortening antimicrobial courses of therapy on the gut microbiome:
www.idsociety.org/science-spea...
www.idsociety.org/science-spea...
Reposted by Christopher Graber
Deadline approaching! Submit your team of ID trivia powerhouses to compete in IDBugBowl, a Jeopardy-style competition held at #IDWeek2025: buff.ly/JUFUcel
IDWeek will pay FULL conference registration for student, resident & fellow team participants.
Apply by 5/16.
IDWeek will pay FULL conference registration for student, resident & fellow team participants.
Apply by 5/16.
May 5, 2025 at 6:33 PM
Deadline approaching! Submit your team of ID trivia powerhouses to compete in IDBugBowl, a Jeopardy-style competition held at #IDWeek2025: buff.ly/JUFUcel
IDWeek will pay FULL conference registration for student, resident & fellow team participants.
Apply by 5/16.
IDWeek will pay FULL conference registration for student, resident & fellow team participants.
Apply by 5/16.
Reposted by Christopher Graber
It takes a village! So many past/present/future fellows on this paper examining Karius utilization: most clinical impact seen with cx neg IE and concern for fastidious/zoonotic/vectorborne pathogens
www.cambridge.org/core/journal...
www.cambridge.org/core/journal...
Real-world clinical impact of plasma cell-free DNA metagenomic next-generation sequencing assay | Infection Control & Hospital Epidemiology | Cambridge Core
Real-world clinical impact of plasma cell-free DNA metagenomic next-generation sequencing assay - Volume 46 Issue 5
www.cambridge.org
April 28, 2025 at 2:55 PM
It takes a village! So many past/present/future fellows on this paper examining Karius utilization: most clinical impact seen with cx neg IE and concern for fastidious/zoonotic/vectorborne pathogens
www.cambridge.org/core/journal...
www.cambridge.org/core/journal...
get those applications in!
Test your ID knowledge at #IDWeek2025 and apply to participate in one of our most popular events! All student, resident and fellow participants on each team selected for #IDBugBowl will have their conference registration paid for by IDWeek.
Apply: idweek.org/events/bugbowl/
Apply: idweek.org/events/bugbowl/
April 26, 2025 at 2:38 PM
get those applications in!
so I am starting to bring up lessons I have learned from Dan Campbell (Detroit Lions coach) in talks on leadership in antimicrobial stewardship. Question from a colleague: What is the ASP equivalent of going for it on 4th down?
April 24, 2025 at 5:14 PM
so I am starting to bring up lessons I have learned from Dan Campbell (Detroit Lions coach) in talks on leadership in antimicrobial stewardship. Question from a colleague: What is the ASP equivalent of going for it on 4th down?